Clinical trial

Bucillamine Study of Holding Remission After Infliximab Dose-off

NCT00716248

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2007-01-01

PhasePHASE4

Study timeline

Study start (unknown)2007-01-01Date precision: month

Registry last updated2011-01-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

bucillamineDRUG

methotrexateDRUG · verified · RxNorm: methotrexate

Sponsors & collaborators

Saitama Medical Universitylead sponsor

Keio Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00716248 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.